Scientific Reports, 2022 · DOI: 10.1038/s41598-021-04222-7 · Published: January 13, 2022
This study explores how two growth factors, VEGF and PDGF, affect Schwann cells (SCs) in an inflammatory environment, relevant to spinal cord injury (SCI) treatment. SCs are important for nerve repair, and combining them with growth factors could enhance regenerative outcomes after SCI. The researchers found that inflammation reduces the ability of SCs to clear myelin debris, a key obstacle after SCI. However, adding VEGF and PDGF, particularly PDGF, improved the SCs' myelin-clearing ability even in the presence of inflammation. PDGF also reduced the production of a pro-inflammatory cytokine (TNF-α) by SCs, suggesting it can create a more favorable environment for nerve regeneration. These findings suggest that using VEGF and/or PDGF with SC transplantation could be beneficial for SCI therapy.
Combining VEGF and/or PDGF with SC transplantation may improve regenerative outcomes in SCI.
PDGF can be used to enhance SC-mediated myelin phagocytosis in a pro-inflammatory environment.
PDGF can reduce the risk of further damage to the surrounding environment by suppressing pro-inflammatory cytokine TNF-α.